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Objectives: To analyse whether contralateral occlusion represents an additional perioperative risk factor in carotid 
endarterectomy (CEA), and whether long-term survival after surgery in patients with contralateral occlusion differs from 
that of patients without. 
Design: Retrospective clinical study. 
Setting: Vascular Surgery Unit, Department of Surgery, University of Perugia, Perugia, Italy. 
Materials: Fifty-five patients with carotid stenosis and contralateral occlusion undergoing CEA (Group I) were compared 
with 110 patients (Group II), without contralateral occlusion selected from a cohort of 367 patients with a patent 
contralateraI rtery, matched for gender, age and ipsilateraI symptoms. 
Chfef outcome measures: Perioperative stroke~death rate at 30 days and minor complications in Group I vs. Group II over 
a mean follow-up of 38 months. 
Main results: The perioperative stroke~death rate at 30 days was 0% in Group I and 2.7% in Group II (p = 0.6) while 
minor complications amounted to 11% in Group land 5% in Group II (p = 0.2). Survival rates of patients free from stroke, 
using Kaplan Meier curves, were 79.4% in Group I and 83.3% in Group II (p = 0.4); stroke free rates were 92.8% and 
94.3% in Groups I and II, respectively. The incidence of late stroke, fatal or not, in patients who had undergone CEA with 
contralateraI obstruction was the same as in similarly operated patients without contralateral obstruction (7% vs. 6%). 
However, the incidence of late vascular death, exemplified by a crude rate of 14% vs. 6% (p = 0.1; O.R. = 2.50; 
C.I. = 0.77-8.25) was greater in patients with contralateral occlusion. 
Conclusions: In this study, CEA in patients with contralateral occlusion was not associated with an increased 
perioperative morbidity~mortality rate. The higher incidence of vascular death in the late follow-up of patients with 
contralateral carotid occlusion, although not statistically significant, could indicate the presence of more severe systemic 
vascular disease. 
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Introduction 
The advantage of carotid endarterectomy (CEA) is 
well established for symptomatic arotid stenosis 
greater than 70% 1,2 In contrast, recent rials compar- 
ing the efficacy of surgery and medical treatment in 
asymptomatic carotid stenosis have provided conflict- 
ing results. 3'4 However, trials such as the Asympto- 
matic Carotid Surgery Trial (ACST) in Europe and the 
Asymptomatic Carotid Atherosclerosis Study (ACAS) 
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in North America are currently ongoing. There are 
some other subgroups of patients in whom the 
indication for CEA has not yet been clearly defined, 
such as those with carotid stenosis and occlusion of 
the contralateral internal carotid. Prospective studies 
have failed to clarify the situation because they were 
carried out with different surgical techniques 5 or 
because this subgroup was not analysed ~ or was too 
small and not homogenous. 6"7 Retrospective studies 
are numerous, although less reliable, s'9 and have 
provided conflicting results. 1°-21 
The aim of the present retrospective study was to 
ascertain whether contralateral occlusion represents 
per se an additional perioperative risk factor in CEA 
and if so, whether this risk is acceptable. We also 
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looked at whether long-term survival after surgery in 
patients with contralateral occlusion differs from that 
of patients without. Patients operated for CEA with 
contralateral occlusion were compared with patients 
operated for CEA without contralateral carotid occlu- 
sion, with regard to early and late morbidity and 
mortality. In an attempt to reduce the bias of previous 
retrospective studies, 8'9 the control group (carotid 
stenosis without contralateral occlusion) was selected 
so as to rninimise the impact of chronological and 
demographic differences. 
Patients and Methods 
From 1987 to 1991, at the Vascular Surgery Unit of the 
Department of Surgery and Surgical Emergencies at 
the University of Perugia, 487 CEAs were performed 
on 422 patients. Fifty-five of these patients had carotid 
stenosis and contralateral occlusion (Group I) and 
were matched with 110 patients (Group II) without 
contralateral occlusion on a 1:2 ratio. Patients in 
Group II were selected from a cohort of 367 patients 
undergoing surgery for carotid stenosis and a patent 
contralateral rtery during the same period. Thus the 
two groups were homogeneous for gender, age and 
symptoms ipsilateral to the artery on which surgery 
was performed. To avoid changes in management 
over time, the patients in the control group were 
selected in such a way that the time between the 
operation of each Group I patient and each "matched" 
Group II couple was not more than 12 months. Risk 
factors were similar in the two groups: hypertension, 
alcohol consumption, smoking, diabetes mellitus, 
hyperlipidaemia, schaemic heart disease, and family 
history of cerebrovascular events. For hypertension, 
we considered one of the following parameters: (a) 
diastolic blood pressure > 95 mmHg and/or systolic 
blood pressure > 180 mmHg in two different record- 
ings either before surgery or at least 1 week after 
surgery; (b) current reatment with antihypertensive 
drugs: for alcohol, > 50 g consumption per day; for 
smoking, > 10 cigarettes per day; for diabetes mellitus 
one of the following parameters was considered: (a) 
therapy with specific drugs; (b) two or more abnormal 
results of glucose concentration (> 120 mg fasting) 
before and/or a week after surgery; for hyper- 
lipidaemia, cholesterol > 220 rag/100 ml; for coronary 
artery disease, a history of ischaemic heart disease 
(myocardial infarction and/or angina), z2 The indica- 
tions for surgery and the operative findings were 
evaluated in both groups. All patients underwent 
intraarterial ngiography. Carotid stenosis was classb 
fled according to the criteria of the ECST: severe 
( > 70%), moderate (30-69%) and mild ( < 30%). 2 
Plaque ulceration was evaluated at surgery. The 
incidence of perioperative complications was 
recorded. The status of the contralateral carotid artery 
was also evaluated in Group II. All neurological 
evaluations, before and after surgery and during 
follow-up, were performed by a neurologist inde- 
pendent of the surgical team. 
Surgery was performed according to standard 
techniques: local or general anaesthesia; systemic 
heparin; stump pressure measurement; selective 
shunt; cerebral monitoring by electroencephalogram 
(EEG) mapping (1987-1989), clinical evaluation under 
local anaesthesia (1988-1991) and transcranial Dop- 
pler (1991). When the patient was under geli~al 
anaesthesia, the criteria for shunt insertion were: 
deterioration of EEG a3 or a reduction of > 65% in the 
basal velocity of the middle cerebral artery at tran- 
scranial Doppler sonography (TCD). 24 Carotid clamp- 
ing with a stump pressure of <50 mmHg was 
considered a risk for homolateral hemispheric schae- 
mia.23, 25, 26 Under local anaesthesia, the appearance of
focal or global symptoms (i.e., unconsciousness) was 
an indication for the use of shunt, independent of 
stump pressure and TCD measurement. 
Reimplantation was performed if significant kink- 
ing was present and a saphenous or polytetrafluoro- 
ethylene (PTFE) patch was used when the internal 
carotid artery was small (< 4 ram) or in cases of 
difficult or unsafe end-point. Neurological complica- 
tions were subdivided into central and peripheral. The 
central complications were subdivided into Transient 
Ischaemic Attacks (TIAs) including retinal ischaemia, 
minor strokes (symptom regression within 1 week) 
and major strokes (persistence of symptoms for more 
than 1 week). 2Peripheral neurological complications 
were those related to the surgical approach. 
The residual disability of the neurological complica- 
tions was evaluated according to a modified Rankin 
scaleY Follow-up extended to 6 years with a mean of 
38 months (range 18-72 months) and was carried out 
on all patients by telephone interview and by clinical 
examination when a deficit was present. All deficits 
that lasted more than 6 months after surgery with a 
score value equal or greater than 3 (major disabling 
stroke) that modified the normal iving habits of the 
patient were considered major complications. 
Statistical comparison was performed with chi- 
square test, Fisher's exact test, Odds ratio (Epiinfo 
software) and log rank test for Kaplan Meier survival 
curves. 8 
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Results 
The mean age in Group I was 66 years (range 47-78) 
and in Group II 66 years (range 46-77). Male to female 
ratio was 15:1. In both groups, 35% of the arteries 
being operated on were associated with ipsilateral 
Table 1. Risk factors 
Group I Group II 
(n = 55) (n = 110) 
Risk factors Patients % Patients % O.R. 95% C.I. p value 
Hypertension 28 51 43 39 1.62 0.80-3.27 0.2 
Alcohol 7 13 20 18 0.66 0.23-1.79 0.5 
Smoking 13 24 36 33 0.64 0.28-1.41 0.3 
Diabetes 8 15 18 16 0.87 0.32-2.32 0.9 
Hyperlipidaemia 14 25 21 19 1.45 0.62-3.34 0.4 
Coronary 
artery disease 13 24 30 27 0.95 0.42-2.16 0.9 
Family history 12 22 30 27 0.74 0.32-1.70 .5 
O.R. = odds ratio; C.I. = confidence interval 
symptoms. Risk factors are reported in Table 1. 
Hypertension was prevalent in Group I (51% vs.  39%) 
but the difference was not statistically significant 
Table 2. Indication for surgery 
Group I Group II 
(n=55) (n=110) 
Patients % Patients % O.R. 95% C.I. p value 
Ipsilateral 
symptoms 19 35 38 35 
TIA+ minor stroke* 11 20 23 21 0.95 0.39-2.26 0.9 
Major stroker 8 15 15 14 1.08 0.39-2.95 0.9 
Contralateral 
symptoms 22 40 5 4 14 4.6-50.1 <0.001 
Asymptomatic or 
nonhemispheric 
symptoms 14 25 67 61 0.22 0.10-0.47 <0.001 
* Minor stroke: symptoms regressed within I week. 
t Major stroke: persistence of symptoms for more than I week. 
TIh = Transient ischaemic attack. 
Other abbreviations as in Table 1. 
(p = 0.2). Table 2 details the indications for surgery. 
Many patients (40%) in Group I had hemispheric 
symptoms on the side of the occluded carotid artery, 
while in 35% of the cases surgery was indicated for 
symptoms ipsilateral to the carotid stenosis and in 
25% for nonhemispheric symptoms or asymptomatic 
carotid stenosis. In the control group, because it was 
necessary to select patients homogeneous to those o f  
Group I for ipsilateral symptoms (35%), we had a h igh  
percentage of patients asymptomatic or with non- 
hemispheric symptoms (61%). Thus, the two groups 
were comparable for incidence of ipsilateral symp- 
toms, although there were differences in the incidence 
of contralateral vs.  nonhemispheric symptoms or 
asymptomatic stenosis, which were statistically sig- 
nificant (p<0.001). Twenty-three percent of the 
patients in the control group had a severe contralateral 
stenosis and were operated on during follow-up and 
58% had a moderate contralateral stenosis. Data on the 
degree of ipsilateral stenosis, plaque morphology and 
use of patch were homogeneously distributed (Tables 
Table 3. Operative data 
Group I Group II 
(n = 55) (n = 110) 
Operative data Patients % Patients % O.R. 95% C.I. p value 
Mild stenosis 1 2 3 3 0.66 0.01-8.47 1 
Moderate stenosis 7 13 20 18 0.66 0.23-1.79 0.5 
Severe stenosis 47 85 87 79 1.55 0.60--4.12 0.4 
Ulcer 32 58 52 47 1.55 0.77-3.15 0.2 
Abbreviations a in Table 1. 
3 and 4). The mean stump pressures were significantly 
lower in Group I (Table 5). Table 6 shows the patients 
in both groups with stump pressure < 50 mmHg: 40% 
vs.  11% ( < 0.001; O.R. 5.44; C.I. 2.27-13.23). Shunt was 
used accordingly: 17 patients in Group I and 5 patients 
in Group II (31% vs.  5%, p < 0.001). In 10 patients of 
Group 1 and 2 patients of Group II, all under general 
anaesthesia, the decision to use a shunt was made on 
the basis of stump pressure alone ( < 50 mmHg) since 
EEG mapping and TCD were not available. For the 
other patients under local anaesthesia the use of a 
shunt was based on clinical assessment, independent 
of low stump pressure and/or  TCD values. 
The stroke and death rates of patients undergoing 
CEA in our Unit from 1987 to 1991 was 2.79% for 
patients and 2.42% for procedures. In the present 
stud)~ none of the patients in Group I had major 
perioperative complications, while 3 patients in Group 
II had a major disabling stroke, 1 being eventually 
fatal and 1 contralateral to CEA. This difference was 
not statistically significant (p = 0.5) (Table 7). Minor 
neurological and non fatal cardiac complications are 
shown in Table 8: minor neurological complications 
were more frequent in Group I (9% vs.  4%) although 
the difference was not statistically significant. 
The crude rate of late vascular death, both cardiac 
and cerebral, was 14% in Group I compared to 6% in 
Group II; there was a greater frequency of cardiac 
events of 9% and 5%, respectively, although the 
difference was not statistically significant. Other 
causes of death during follow-up were neoplasm (3) 
and trauma (1) and are reported in Table 9. The 
incidence of late myocardial infarction, fatal or not, 
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Table 4. Operative data 
Group I Group II 
(n = 55) (n = 110) 
Operative data Patients % Patients % O.R. 95% C.I. p value 
Local anaesthesia 33 60 71 65 
Shunt 17 31 5 5 9.39 3.01-34.32 <0.001 
Patch 31 56 59 54 0.77 0.38-1.56 0.5 
Abbreviations a in Table 1. 
Table 5. Stump pressure. Values are mean (_+ S.D.) 
Mean stump 
pressure Range 
(mmHg) S.D. + (mmHg) 
Group I (n=55) 52.3 19.7 (10-98) 
Group II (n=110) 68 19.6 (20-120) 
p < 0.001. 
Table 6. Shunt and stump pressure 
Group I Group II 
(n=55) (n=110) 
Patients % Patients % O,R. 95% C.I. p value 
Shunt 17 31 5 5 9.39 3.1-34.32 <0.001 
Stump < 50 mmHg 22 40 12 11 5.44 2.27-13.23 < 0.001 
Shunt 15 27 3 3 
Stumpa50mmHg 33 60 98 89 0.18 0.08-0.44 <0.001 
Shunt 2 4 2 2 
Abbreviations a  in Table 1. 
Table 7. Perioperative death and stroke rate 
Group I Group II 
(n = 55) (n = 110) 
Patients % Patients % O.R. 95% C.I. pvalue 
Stroke* 0 0 2t 2 
Death 0 0 1:~ 1 
Total 0 0 3 2.7 0 04.85 0.5 
* Only major disabling stroke. 
t One contralateral stroke. 
$ Fatal stroke. 
Abbreviations a in Table 1. 
Table 8. Perioperative complications (cardiac and minor 
neurological) 
Group I Group II 
(n = 55) (n = 110) 
Patients % Patients % O.R. 95%C.I. pvalue 
Neurological* 5 9 5 4 2.10 0.46-9.53 0.3 
Cranial nerve 
injuryt 1 2 0 0 
Angina 0 0 1 1 
Myocardial 
infarction 0 0 0 0 
Total 6 11 6 5 2.12 0.53-8.35 0.2 
* Transient ischaemic attack (two in each group) or any non disabling 
stroke. 
t Transient. 
Abbreviations a in Table 1. 
Table 9. Late death 
Group I Group II 
(n=55) (n=110) 
Patients % Patients % O.R. 95% C.I. p value 
Vascular death 
(cardiac+ 
cerebral) 8 14 7 6 2.50 0.77-8.25 0.1 
Cardiac 5 9 6 5 1.73 0.40-7.16 0.5 
Stroke 3 5 1 1 6.29 0.49-333 0.1 
Other 2 4 2 2 2.04 0.14-28.69 0.6 
Total 10 18 9 8 2.49 0.86-7.26 0.1 
Crude rate: mean 38.4 months. 
Abbreviations a in Table 1. 
and  of all strokes last ing more than 1 week (major 
strokes) are shown in Table 10. Similarly, the surv ival  
curves with or wi thout  d isabl ing stroke were not 
statistically significant. The stroke free rate was 94.3% 
for Group I and  92.8% for Group II (p = 0.8) (Fig. 1). 
Dur ing  the 6 year fo l low-up about  6% and 7% had a 
d isabl ing or fatal stroke, respectively. The surv ival  rate 
of pat ients free from stroke was 79.4% in Group I and  
83.3% in Group II (p = 0.4) (Fig. 2). 
Discussion 
The natura l  history of pat ients with carotid stenosis 
and contralateral obstruct ion is poor ly  def ined due to 
several reasons: carotid obstruct ion can be asympto-  
matic; in pat ients who die short ly after a severe stroke 
due to carotid occlusion, diagnosis with Duplex-  
scann ing or ang iography is not a lways possible. In 
pat ients with ischaemic symptoms related to the 
carotid terr itory and  with  ipsi lateral occlusion, it is 
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Table 10. Late myocardial infarction and any stroke lasting more 
than 7 days 
Group I Group II 
(n=55) (n=110) 
Patients % Patients % O.R. 95% C.I. p value 
Any stroke 3* 5 8t 7 0.74 0.12-3.24 0.7 
Myocardial 
infarction 6:~ 11 8§ 7 1.56 0.42-5.44 0.5 
Total 9 16 16 14 1.15 0.43-3.03 0.9 
* Fatal, two ipsflateral nd one contralateral (occluded side). 
t One fatal (ipsilateral, three disabling (two ipsilateral and one VB), 
four non-disabling (two ipsilateral and two contralateral). 
:~ F ive  fatal. 
§ Six fatal. 
Late Transientischaemic attack were one per Group. No minor stroke 
(i.e. lasting less than 7 days) during follow-up. 
Crude rate: mean 38.4 months ,  range  18-72. 
Abbreviations as in Table 1. 
difficult to establish exactly whether the occlusion was 
causing the symptoms or was preceded by an embolis- 
ing tight stenosis. The incidence of stroke due to 
carotid obstruction can therefore be either overesti- 
mated or underestimated. 2s Faught et al. stated that 
40% of strokes take place after carotid obstruction, one 
third of which are disabling. 29 The overall incidence of 
stroke per year for this category of patients varies 
from 6%-8%.  29'30 Since many of these prospective 
studies do not define the status of the contralateral 
artery, it is possible that the presence of a severe 
stenosis on the same side worsens the prognosis. 
In our study, patients with stenosis and con- 
tralateral occlusion had symptoms on the side of the 
obstruction i  40% of the cases. In 35% of the cases the 
indication for surgery was determined by symptoms 
ipsilateral to the stenosis. Therefore, in 75% the 
surgical indication was a hemispheric event. Since one 
of the parameters used to select he control group was 
the presence of ipsilateral symptoms to the operated 
carotid, it followed that in Group II the presence of 
asymptomatic patients was statistically higher, 61% vs. 
25% p < 0.001, O.R. 0.22, C.I. 0.10-0.47. In our opinion, 
this difference should not bias the results as the aim of 
our study was to establish if the perioperative compli- 
cations and the late events in patients operated on for 
CEA differed as regards the absence or presence of an 
occluded contralateral carotid. The high incidence of 
asymptomatic patients in Group II (those with a 
patent contralateral carotid), whose long-term prog- 
nosis is better, 3~-33 would maximise any difference in 
early and late results between the two groups. 
The perioperative stroke and death rate is of crucial 
importance for defining the indication for CEA in 
carotid stenosis with contralateral occlusion. The Joint 
Study of Extracranial Arterial Occlusion of 1976 
favoured medical treatment only. 5 Although more 
recent data from NASCET 6 indicate that contralateral 
occlusion imposes an increased perioperative stroke 
rate (14.2%), the outlook in the medically treated 
patients was much worse than in those who under- 
went surgery: the risk of stroke at 2 years in the 
surgically treated group was 20.4% vs. 56.4% in the 
medically treated. Nevertheless, the cohort of patients 
in this study with contralateral occlusion was too 
small (n = 21) to reach statistical significance. 
A review of the literature based on retrospective 
studies reveals contrasting opinions about the oper- 
ative risks in such patients. The incidence of major 
complications reported varies from a minimum of 
0%2~ to a maximum of 17.6%. 5Lesage et aI. reported a
9.8% perioperative stroke/death rate; all patients 
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Fig. 1. Stroke-free rates by Kaplan Meier curves in Group I and Group II. (----) Group I; ( - - )  Group II. Log rank test: p = 0.8. *Number of 
patients in Group I for each interval. §Number of patients in Group II for each interval. 
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underwent surgery without the use of shuntJ 8 Con- 
verse134 Riles et al. recently reported that, in patients 
operated after 1985 a shunt was used in 52% of the 
cases and the stroke rate was 0.7%. 16 Our major 
complications (death + disabling stroke) were more 
frequent in the control group (2.7% vs. 0%) although 
the difference was not statistically significant (p = 0.5). 
It should be noted that stump pressure was sig- 
nificantly lower in Group I (52.3+/-19.7 vs. 
68 +/-19.6; p < 0.001). These lower mean values are 
probably the reflection of a poorer collateral circula- 
tion in the contralateral hemisphere, thus indicating a
potentially greater perioperative risk in the patients of 
Group I, which is in agreement with the more frequent 
use of shunt in these patients. 
Even if patients with stump pressure < 50 mmHg 
were more frequent in Group I (Table 6), the predictive 
power of this measurement for clamping ischaemia 
cannot be inferred. This is because we employed other 
monitoring procedures including EEG, TCD and local 
anaesthesia, making a comparison between these 
procedures unreliable due to insufficient numbers. 
However, there is agreement among authors that the 
predictive value of stump pressure measurement 
alone is low. 26 For this reason, we chose < 50 mmHg 
(at normal systemic pressure) as the threshold value 
below which a shunt should be inserted, in those cases 
where no other cerebral monitoring system was 
possible. In addition, we believe that a more liberal 
use of shunt (more frequently used in Group I than in 
Group II; 31% vs. 5%; p <0.001; O.R. 9.39; C.I. 
3.01-34.32) could be effective in lowering the perioper- 
ative stroke/death rate in patients with contralateral 
carotid occlusion. In contrast, minor neurological 
complications, TIA and non disabling stroke, were 
more frequent in Group I (9% vs. 4%) (Table 8). 
However, the difference was not statistically 
significant. 
The long term stroke-free rate at 6 years did not 
differ between the two groups (Group h 94.3%; Group 
II: 92.8%). Likewise stroke-free survival appeared to 
be similar (79.4% and 83.3% in Groups I and II, 
respectively), with a stroke/death rate per year of 
3.4% and 2.8%, respectively. The late stroke-free 
survival rates of our operated patients are analogous 
to those reported by other authors. 17A9'2° Mattos et al. 
reports slightly worse results (60.7% and 77.5%, 
respectively) but even in this case there were no 
statistically significant differences in the two groupsY 
Analysis of the crude mortality rate reveals that the 
cause of vascular death (either cardiac or cerebral) is 
14% vs. 6%. However, on considering all vascular 
events (i.e. fatal and non fatal myocardial infarctions 
and all strokes resulting in deficit longer than 7 days) 
this difference, statistically insignificant, tends to 
disappear (16% vs. 14%). Therefore, the higher ate of 
late vascular mortality of patients with carotid occlu- 
sion described by other authors is only partially 
confirmed by our study. 17'29 
In conclusion, our results how that CEA in patients 
with contralateral occlusion is not associated with an 
increased perioperative morbidity/mortality rate. 
However, accurate cerebral monitoring, extensive use 
of shunt and adherence tooptimal surgical techniques 
is required in these patients. Late survival, including 
the stroke-free rate, is no different in patients with 
contralateral obstruction and better than that pre- 
dicted by the disease natural history. The higher 
incidence of vascular death at the late follow-up (14% 
vs. 6%), although not statistically significant, could 
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Fig. 2. Stroke-free survival rates by Kaplan Meier curves in Group I and Group II. (----) Group I; (--) Group II. Log rank test: p = 0.4. 
*Number of patients inGroup I for each interval. §Number of patients inGroup II for each interval. 
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indicate the presence of more severe systemic vascular 
disease in patients with contralateral carotid 
occlusion. 
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